Your browser doesn't support javascript.
loading
CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells.
Hartl, Leonie; Duitman, JanWillem; Aberson, Hella L; Chen, Kan; Dijk, Frederike; Roelofs, Joris J T H; Dings, Mark P G; Hooijer, Gerrit K J; Hernanda, Pratika Y; Pan, Qiunwei; Busch, Olivier R; Besselink, Marc G H; Boerman, Ton; Peppelenbosch, Maikel P; Bijlsma, Maarten F; Spek, C Arnold.
Affiliation
  • Hartl L; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Duitman J; Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, 1182 DB Amsterdam, The Netherlands.
  • Aberson HL; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Chen K; Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, 1182 DB Amsterdam, The Netherlands.
  • Dijk F; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Roelofs JJTH; Department of Gastroenterology and Hepatology, Erasmus Medical Center, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Dings MPG; Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, 1182 DB Amsterdam, The Netherlands.
  • Hooijer GKJ; Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Hernanda PY; Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Pan Q; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Busch OR; Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, 1182 DB Amsterdam, The Netherlands.
  • Besselink MGH; Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Boerman T; Laboratory of Medical Genetics, University of Wijaya Kusuma Surabaya, Jawa Timur 60225, Indonesia.
  • Peppelenbosch MP; Department of Gastroenterology and Hepatology, Erasmus Medical Center, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Bijlsma MF; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, 1182 DB Amsterdam, The Netherlands.
  • Spek CA; Hepato-Pancreato-Biliary Surgery, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Cancers (Basel) ; 12(9)2020 Sep 07.
Article in En | MEDLINE | ID: mdl-32906832
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Netherlands